These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31630449)

  • 1. Bacteremia and urogenital infection with Actinomyces urogenitalis following prolonged urinary retention.
    Holmgaard DB; Marina D; Hansen F; Christensen JJ
    APMIS; 2020 Jan; 128(1):20-24. PubMed ID: 31630449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actinomyces urogenitalis bacteremia and tubo-ovarian abscess after an in vitro fertilization (IVF) procedure.
    Van Hoecke F; Beuckelaers E; Lissens P; Boudewijns M
    J Clin Microbiol; 2013 Dec; 51(12):4252-4. PubMed ID: 24025912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrauterine contraceptive device-associated pelvic actinomycosis caused by Actinomyces urogenitalis.
    Elsayed S; George A; Zhang K
    Anaerobe; 2006 Apr; 12(2):67-70. PubMed ID: 16701616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility of clinical isolates of Actinomyces and related genera reveals an unusual clindamycin resistance among Actinomyces urogenitalis strains.
    Barberis C; Budia M; Palombarani S; Rodriguez CH; Ramírez MS; Arias B; Bonofiglio L; Famiglietti A; Mollerach M; Almuzara M; Vay C
    J Glob Antimicrob Resist; 2017 Mar; 8():115-120. PubMed ID: 28109846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Our experiences with Actinomyces urogenitalis in human clinical samples].
    Ježek P; Šafránková R; Mališová L
    Klin Mikrobiol Infekc Lek; 2020 Mar; 26(1):12-17. PubMed ID: 33326590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance rates to commonly used antimicrobials among pathogens of both bacteremic and non-bacteremic community-acquired urinary tract infection.
    Lau SM; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2004 Jun; 37(3):185-91. PubMed ID: 15221039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteus mirabilis urinary tract infection and bacteremia: risk factors, clinical presentation, and outcomes.
    Chen CY; Chen YH; Lu PL; Lin WR; Chen TC; Lin CY
    J Microbiol Immunol Infect; 2012 Jun; 45(3):228-36. PubMed ID: 22572004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary
    Kashiwagi R; Watari T; Oshiro A; Kikuchi K
    BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36593624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repetitive urinary tract infections and two prostatic masses: Prostatic soft tissue infection with Actinomyces neuii.
    Groeneveld GH; Veldkamp KE; van Dissel JT
    Int J Infect Dis; 2019 Sep; 86():55-56. PubMed ID: 31288092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actinomyces turicensis Bacteremia Secondary to Pyometra.
    Hagiya H; Ogawa H; Takahashi Y; Kimura K; Hasegawa K; Otsuka F
    Intern Med; 2015; 54(21):2775-7. PubMed ID: 26521910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of Urine Cultures in Predicting Blood Culture Susceptibilities in Patients with Bacteremic Urinary Tract Infection.
    Lam PW; Wiggers JB; Lo J; MacFadden DR; Daneman N
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30323048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parenteral polymyxin B use in patients with multidrug-resistant gram-negative bacteremia and urinary tract infections: a retrospective case series.
    Pastewski AA; Caruso P; Parris AR; Dizon R; Kopec R; Sharma S; Mayer S; Ghitan M; Chapnick EK
    Ann Pharmacother; 2008 Sep; 42(9):1177-87. PubMed ID: 18664609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actinomyces bacteremia in association with tubo-ovarian abscesses and hysteroscopic sterilization.
    Pakish JB; West L
    Obstet Gynecol; 2014 Aug; 124(2 Pt 2 Suppl 1):451-453. PubMed ID: 25004324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteremic and non-bacteremic febrile urinary tract infection--a review of 168 hospital-treated patients.
    Jerkeman M; Braconier JH
    Infection; 1992; 20(3):143-5. PubMed ID: 1644489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Characteristics of
    Hsiao YC; Lee YH; Ho CM; Tseng CH; Wang JH
    Medicina (Kaunas); 2021 Oct; 57(10):. PubMed ID: 34684101
    [No Abstract]   [Full Text] [Related]  

  • 16. Application of Fluoroquinolone Resistance Score in Management of Complicated Urinary Tract Infections.
    Shah A; Justo JA; Bookstaver PB; Kohn J; Albrecht H; Al-Hasan MN
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28193655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous-only or Intravenous Transitioned to Oral Antimicrobials for Enterobacteriaceae-Associated Bacteremic Urinary Tract Infection.
    Rieger KL; Bosso JA; MacVane SH; Temple Z; Wahlquist A; Bohm N
    Pharmacotherapy; 2017 Nov; 37(11):1479-1483. PubMed ID: 28869655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actinomyces neuii and neonatal sepsis.
    Mann C; Dertinger S; Hartmann G; Schurz R; Simma B
    Infection; 2002 Jun; 30(3):178-80. PubMed ID: 12120948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteremia secondary to Alloscardovia omnicolens urinary tract infection.
    Ogawa Y; Koizumi A; Kasahara K; Lee ST; Yamada Y; Nakano R; Yano H; Mikasa K
    J Infect Chemother; 2016 Jun; 22(6):424-5. PubMed ID: 26829996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated pathogens and clinical outcomes of adult bacteremia in the emergency department: a retrospective study in a tertiary Referral Center.
    Kao CH; Kuo YC; Chen CC; Chang YT; Chen YS; Wann SR; Liu YC
    J Microbiol Immunol Infect; 2011 Jun; 44(3):215-21. PubMed ID: 21524617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.